| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |